(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.


Figure 5


Fig. 5. (A) Concentration-dependent decrease in mean force in response to adenosine. A statistically significant decrease was obtained at >=10 µmol l–1 in prometamorphosis (N=12), at >=100 µmol l–1 in metamorphosis (N=6) and at >=300 µmol l–1 in juveniles (N=12). (B) Concentration-dependent decrease in mean force in response to N6-cyclopentyladenosine (CPA) in prometamorphosis (N=8), metamorphosis (N=11) and juveniles (N=10). Statistically significant decrease obtained at >=1 µmol l–1 for all stages. Control value prior to administration of agonist is denoted C on the x-axis. Statistical analysis was performed using repeated measures one-way ANOVA followed by Dunnett's post hoc test (A,B). (C) Effect of adenosine in the presence and absence of the A1 receptor antagonist DPCPX (1 µmol l–1) in prometamorphic (100 µmol l–1 adenosine, N=4) and juvenile (1000 µmol l–1 adenosine, N=9) stomach muscle strips. Statistical analysis was performed using repeated measures one-way ANOVA followed by Bonferroni's post hoc test. Asterisk indicates P<0.05. (D) Effects of the adenosine kinase inhibitor 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine (ABT-702, 1 µmol l–1) on mean force developed under control conditions in prometamorphic (N=7) and juvenile (N=10) tissues. Statistical significance was calculated using Student's t-test for paired observations. Asterisk indicates P<0.05.